Article

Oncology Practice Leaders Refocusing Efforts to Improve Long Term Viability

Oncology practices are experiencing acute challenges in today’s rapidly changing healthcare environment. Costs for treating patients are increasing, regulatory changes are affecting the way practices operate, and there are significant changes in reimbursement — compounded by a 2% reduction in fees as a result of the recent sequestration. In addition, payers are moving away from the traditional fee-for-service payment model towards value-based models that recognize quality and patient outcomes.

These shifts require practice leadership to make preserving or increasing revenue and cash flow a top priority. After all, practices cannot provide care if they cannot afford to stay in business. So, how should practice leaders re-tool and re-focus their efforts to keep their practices financially viable and thriving in these challenging times?

Read the full story here: http://bit.ly/YF6GpB

Source: OBROncology.com

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Cathy Eng, MD, FACP, FASCO
Leigh Maria Ramos-Platt, MD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Molly Dean, MSW, Siftwell
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo